On Wednesday, Builders FirstSource, Inc. (BLDR) stock saw a decline, ending the day at $176.78 which represents a decrease of $-4.21 or -2.33% from the prior close of $180.99. The stock opened at $173 ...

Builders FirstSource (BLDR) closed at $172.88 in the latest trading session, marking a +0.75% move from the prior day. The stock outpaced the S&P 500's daily loss of 0.33%. Meanwhile, the Dow lost ...

Shares of Firstsource Solutions were sharply higher by 11% after the company significantly raised its revenue growth guidance for FY25 to 19.5-20.5% in constant currency terms, from an earlier ...

Image Credit: Reuters Google is reportedly working on an advanced AI agent, codenamed Project Jarvis, that will operate directly within web browsers, automating routine online tasks. According to The ...

Builders FirstSource Inc. (NYSE:BLDR), a leading supplier of building materials and construction services, finds itself at a critical juncture as it navigates a complex housing market landscape. The ...

Builders FirstSource Inc. (NYSE:BLDR), a leading supplier of building materials and construction services, finds itself at a critical juncture as it navigates a complex housing market landscape.

“But with other bet builder offerings, esports bettors were often restricted to simple, predefined options, which failed to meet the needs of more engaged users who wanted more control over their bets ...

Fintel reports that on October 25, 2024, UBS initiated coverage of Builders FirstSource (NYSE:BLDR) with a Buy recommendation. Analyst Price Forecast Suggests 15.32% Upside As of October 22 ...

UBS has recently initiated Builders FirstSource, Inc. (BLDR) stock to Buy rating, as announced on October 25, 2024, according to Finviz. Earlier, on October 10, 2024, Goldman had initiated the stock ...

As Paradox Interactive reels from the troublesome launch of Cities: Skylines 2, the company is returning to the first game in the series, which it had apparently moved on from more than a year ago ...

Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia A or B without inhibitors — making it the first antitissue-factor pathway inhibitor to be allowed for ...

Builders FirstSource (NYSE:BLDR) underwent analysis by 20 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below offers a condensed view of their ...